Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Susana Arias Rivera, Hospital Universitario Getafe
ClinicalTrials.gov Identifier:
NCT01646008
First received: July 18, 2012
Last updated: December 2, 2015
Last verified: December 2015
  Purpose
The purpose of this study is to study the correlation between carbon dioxide measured by capnography at the enf of exhalation and arterial blood in COPD patients with nasal cannula in critical care unit.

Condition Intervention
Correlation Between Exhaled Carbon Dioxide and in Arterial Blood
Other: To measure carbon dioxide by capnography and arterial blood
Other: to measure carbon dioxide by capnography and arterial blood

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood in Chronic Obstructive Pulmonary Disease (COPD) in Intensive Care Unit With Nasal Cannula

Resource links provided by NLM:


Further study details as provided by Hospital Universitario Getafe:

Enrollment: 32
Study Start Date: April 2012
Study Completion Date: August 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
respiratory Other: To measure carbon dioxide by capnography and arterial blood
Three times per day will be measured exhaled carbon dioxide and obtained in arterial blood sample.
Other: to measure carbon dioxide by capnography and arterial blood
three times per day we will obtained arterial blood samples and measurements of carbon dioxide by capnography

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All adult COPD patients admitted to the ICU who consent
Criteria

Inclusion Criteria:

  • Adults
  • COPD patients

Exclusion Criteria:

  • Under-aged
  • Pregnant
  • Major burns
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01646008

Locations
Spain
Hospital Universitario de Getafe
Getafe, Madrid, Spain, 28905
Sponsors and Collaborators
Hospital Universitario Getafe
Investigators
Principal Investigator: Susana Arias-Rivera, Graduate Hospital Universitario de Getafe, Spain
  More Information

No publications provided

Responsible Party: Susana Arias Rivera, Registered Nurse, Hospital Universitario Getafe
ClinicalTrials.gov Identifier: NCT01646008     History of Changes
Other Study ID Numbers: Carbon dioxide Getafe 
Study First Received: July 18, 2012
Last Updated: December 2, 2015
Health Authority: Spain: Comité Ético de Investigación Clínica

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Lung Diseases
Lung Diseases, Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on February 04, 2016